Expert Opinions on Positron Emission Tomography and Computed Tomography Imaging in Lymphoma

被引：39

作者：

Delbeke, Dominique ^{[2
]}

Stroobants, Sigrid ^{[3
]}

de Kerviler, Eric ^{[4
]}

Gisselbrecht, Christian ^{[4
]}

Meignan, Michel ^{[5
]}

Conti, Peter S. ^{[1
]}

机构：

[1] Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Univ Hosp, Leuven, Belgium

[4] Hop St Louis, Paris, France

[5] Hop Henri Mondor, F-94010 Creteil, France

来源：

ONCOLOGIST | 2009年 / 14卷

关键词：

Positron emission tomography; Emission-computed tomography; Non-Hodgkin's lymphoma; Imaging; STAGE HODGKINS LYMPHOMA; CORE-NEEDLE BIOPSY; B-CELL LYMPHOMA; RESPONSE ASSESSMENT; INTERNATIONAL WORKSHOP; F-18-FDG PET; FDG-PET; CANCER; CRITERIA; MANAGEMENT;

D O I：

10.1634/theoncologist.2009-S2-30

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Revised guidelines for the staging and response criteria of Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL) were recently published to include the expanding role of positron emission tomography/computed tomography (PET/CT) using F-18-fluoro-2-deoxyglucose. Here, we discuss the new guidelines and the need for standardized PET acquisition and interpretation in HL and NHL. We also discuss how the role for CT is evolving in the process of making treatment decisions and provide insight on how best to standardize the use of PET/CT for making therapeutic choices. The Oncologist 2009; 14(suppl 2):30-40

引用

页码：30 / 40

页数：11

共 55 条

[1]

Comparison between 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma [J].